ACET FY 2013 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$68M

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$500M+12.4% YoY

Gross Profit

$98M19.7% margin

Operating Income

$34M6.9% margin

Net Income

$22M4.5% margin

EPS (Diluted)

$14.88

Cash Flow

Operating Cash Flow

$24M

Free Cash Flow

$23M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$323M

Total Liabilities

$129M

Stockholders' Equity

$195M

Cash & Equivalents

$33M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$500M	$444M	+12.4%
Gross Profit	$98M	$82M	+19.8%
Operating Income	$34M	$25M	+35.7%
Net Income	$22M	$17M	+31.5%